American Journal of Roentgenology, Vol 165, 1453-1459, Copyright © 1995 by American Roentgen Ray Society

ARTICLES

An imaging algorithm for the differential diagnosis of adrenal adenomas and metastases

MM McNicholas, MJ Lee, WW Mayo-Smith, PF Hahn, GW Boland and PR Mueller
Department of Radiology, Massachusetts General Hospital, Boston 02114, USA.

OBJECTIVE. The purpose of this study was to develop an algorithm using CT and chemical-shift MR imaging for the characterization of adrenal masses in patients with a primary cancer and no other evidence of metastatic disease. SUBJECTS AND METHODS. Thirty-three patients with 37 adrenal masses (19 metastases, 18 adenomas), all of whom had a known primary cancer, were studied with noncontrast CT and chemical-shift MR imaging (1.5 T). Lesion size and density in Hounsfield units (H) were determined by CT. Adrenal signal intensity normalized to that of spleen was used to calculate adrenal-spleen ratio (ASR), defined as the percentage of signal remaining in the opposed-phase image relative to the in-phase image. Lesions less than or equal to 0 H were classified as benign, lesions greater than 20 H were regarded as malignant, and lesions between 0 and 20 H were regarded as indeterminate. Diagnoses were confirmed by biopsy (for 19 lesions) or by follow-up imaging (for 18 lesions). An imaging algorithm was derived by determining the relative value of CT and MR imaging for diagnosing the lesions. The reimbursement rates for CT-guided biopsy and MR imaging of the abdomen were obtained from Medicare. RESULTS. All 13 lesions of 0 or less H were correctly classified as benign by CT. ASR was less than 70 in 10 of these 13. In another 13 lesions, H was greater than 20; all were malignant and all had an ASR greater than 80. Of 11 CT-indeterminate lesions, four of five adenomas had an ASR less than 70, and four of six metastases had an ASR greater than 80. Two malignant lesions had ASRs between 70 and 80 and were diagnosed by biopsy findings. One CT- indeterminate adenoma had an ASR of 84 and was diagnosed by biopsy findings. The reimbursement rate by Medicare is similar for CT-guided biopsy with pathologic interpretation and for MR imaging of the abdomen. CONCLUSION. An algorithm was developed for diagnosis of adrenal lesions that uses the density reading on noncontrast CT as the first step, with chemical-shift MR imaging for CT-indeterminate lesions. In this algorithm, lesions of 0 H or less may be regarded as benign and further work-up is not required. Lesions with a density greater than 20 H are likely malignant and should be biopsied when the result will influence management. For CT-indeterminate lesions, we recommend chemical-shift MR imaging. An ASR threshold of 70 indicates a benign lesion, and no further workup is required in these patients. Lesions with an ASR greater than 70 should have a biopsy performed, depending on the clinical situation. The above algorithm is cost- effective and reduces the number of biopsies required without reducing the sensitivity of detecting malignant lesions.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. A. Blake, M. K. Kalra, A. T. Sweeney, B. C. Lucey, M. M. Maher, D. V. Sahani, E. F. Halpern, P. R. Mueller, P. F. Hahn, and G. W. Boland Distinguishing Benign from Malignant Adrenal Masses: Multi-Detector Row CT Protocol with 10-Minute Delay Radiology, December 21, 2005; (2005) 2382041514. [Abstract] [Full Text]

				R Nawar and D Aron Adrenal incidentalomas -- a continuing management dilemma Endocr. Relat. Cancer, September 1, 2005; 12(3): 585 - 598. [Abstract] [Full Text] [PDF]

				A. Thorin-Savoure, F. Tissier-Rible, L. Guignat, A. Pellerin, X. Bertagna, J. Bertherat, and H. Lefebvre Collision/Composite Tumors of the Adrenal Gland: A Pitfall of Scintigraphy Imaging and Hormone Assays in the Detection of Adrenal Metastasis J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4924 - 4929. [Abstract] [Full Text] [PDF]

				A. H. Hamrahian, A. G. Ioachimescu, E. M. Remer, G. Motta-Ramirez, H. Bogabathina, H. S. Levin, S. Reddy, I. S. Gill, A. Siperstein, and E. L. Bravo Clinical Utility of Noncontrast Computed Tomography Attenuation Value (Hounsfield Units) to Differentiate Adrenal Adenomas/Hyperplasias from Nonadenomas: Cleveland Clinic Experience J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 871 - 877. [Abstract] [Full Text] [PDF]

				J. M. Pereira, C. B. Sirlin, P. S. Pinto, and G. Casola CT and MR Imaging of Extrahepatic Fatty Masses of the Abdomen and Pelvis: Techniques, Diagnosis, Differential Diagnosis, and Pitfalls RadioGraphics, January 1, 2005; 25(1): 69 - 85. [Abstract] [Full Text] [PDF]

				G. M. Israel, M. Korobkin, C. Wang, E. N. Hecht, and G. A. Krinsky Comparison of Unenhanced CT and Chemical Shift MRI in Evaluating Lipid-Rich Adrenal Adenomas Am. J. Roentgenol., July 1, 2004; 183(1): 215 - 219. [Abstract] [Full Text] [PDF]

				G. Mansmann, J. Lau, E. Balk, M. Rothberg, Y. Miyachi, and S. R. Bornstein The Clinically Inapparent Adrenal Mass: Update in Diagnosis and Management Endocr. Rev., April 1, 2004; 25(2): 309 - 340. [Abstract] [Full Text] [PDF]

				A. Stadler, W. Schima, G. Prager, P. Homolka, G. Heinz, S. Saini, E. Eisenhuber, and B. Niederle CT Density Measurements for Characterization of Adrenal Tumors Ex Vivo: Variability Among Three CT Scanners Am. J. Roentgenol., March 1, 2004; 182(3): 671 - 675. [Abstract] [Full Text] [PDF]

				F. Fujiyoshi, M. Nakajo, Y. Fukukura, and S. Tsuchimochi Characterization of Adrenal Tumors by Chemical Shift Fast Low-Angle Shot MR Imaging: Comparison of Four Methods of Quantitative Evaluation Am. J. Roentgenol., June 1, 2003; 180(6): 1649 - 1657. [Abstract] [Full Text] [PDF]

				E. P. Chen, C. J. Weber, C. D. Smith, and J. I. Miller Jr Synchronous presentation of primary non-small cell lung carcinoma and pheochromocytoma Ann. Thorac. Surg., September 1, 2002; 74(3): 924 - 926. [Abstract] [Full Text] [PDF]

				S M Lyon and M J Lee Imaging the non-hyperfunctioning adrenal mass Imaging, April 1, 2002; 14(2): 137 - 146. [Abstract] [Full Text] [PDF]

				M. Yun, W. Kim, N. Alnafisi, L. Lacorte, S. Jang, and A. Alavi 18F-FDG PET in Characterizing Adrenal Lesions Detected on CT or MRI J. Nucl. Med., December 1, 2001; 42(12): 1795 - 1799. [Abstract] [Full Text] [PDF]

				M. E. Mullins, S. Chao, H. Dong, and P. J. Slanetz Posttransplantation Non-Hodgkin's Lymphoma of the Adrenal Gland Am. J. Roentgenol., August 1, 2001; 177(2): 336 - 336. [Full Text] [PDF]

				W. W. Mayo-Smith, G. W. Boland, R. B. Noto, and M. J. Lee State-of-the-Art Adrenal Imaging RadioGraphics, July 1, 2001; 21(4): 995 - 1012. [Abstract] [Full Text] [PDF]

				E. M. Remer, N. Obuchowski, J. D. Ellis, T. W. Rice, D. J. Adelstein, and M. E. Baker Adrenal Mass Evaluation in Patients with Lung Carcinoma: A Cost-Effectiveness Analysis Am. J. Roentgenol., April 1, 2000; 174(4): 1033 - 1039. [Abstract] [Full Text] [PDF]

				E. F. Patz Jr, J. J. Erasmus, H. P. McAdams, J. E. Connolly, E. M. Marom, P. C. Goodman, R. A. Leder, M. T. Keogan, and J. E. Herndon Lung Cancer Staging and Management: Comparison of Contrast-enhanced and Nonenhanced Helical CT of the Thorax Radiology, July 1, 1999; 212(1): 56 - 60. [Abstract] [Full Text]

				H. L. Porte, O. J. Ernst, T. Delebecq, D. Metois, L. G. Lemaitre, and A. J. Wurtz Is computed tomography guided biopsy still necessary for the diagnosis of adrenal masses in patients with resectable non-small-cell lung cancer? Eur. J. Cardiothorac. Surg., May 1, 1999; 15(5): 597 - 601. [Abstract] [Full Text] [PDF]

				M. N. Hood, V. B. Ho, J. G. Smirniotopoulos, and J. Szumowski Chemical Shift: The Artifact and Clinical Tool Revisited RadioGraphics, March 1, 1999; 19(2): 357 - 371. [Abstract] [Full Text] [PDF]

				N. J. Khati, M. C. Javitt, and A. M. Schwartz Residents' Teaching Files : Adrenal Adenoma and Hematoma Mimicking a Collision Tumor at MR Imaging RadioGraphics, January 1, 1999; 19(1): 235 - 239. [Full Text] [PDF]

				L. H. Schwartz, M. S. Ginsberg, M. E. Burt, K. T. Brown, G. I. Getrajdman, and D. M. Panicek MRI as an Alternative to CT-Guided Biopsy of Adrenal Masses in Patients With Lung Cancer Ann. Thorac. Surg., January 1, 1998; 65(1): 193 - 197. [Abstract] [Full Text] [PDF]